
Former Ventura County CEO settles sexual harassment lawsuit
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Former Ventura County CEO settles sexual harassment lawsuit
Ventura County and its former CEO, Mike Powers, have agreed to a settlement with a former employee who sued him for alleged sexual and racial harassment and discrimination from 2019 to 2021. A notice of a conditional settlement was filed in Ventura County Superior Court Feb. 24. Terms of the settlement are not disclosed in Read More →

805 law: Siblings challenge state law over Santa Barbara mineral rights
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

805 Law: Central Coast DAs urge residents to keep immigration protests non-violent
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Sable Offshore gets drilling win in fed appeals court
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Nevada healthcare provider sues Amgen for $7M in damages
Sagebrush Health Services, a nonprofit healthcare provider, has sued Thousand Oaks-based biotech giant Amgen for $7 million in damages in a dispute involving a federal drug discount program. Under the 340B Drug Pricing Program, drug manufacturers such as Amgen, in exchange for the benefit of selling their products at full price to federal health insurance Read More →








